Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

@article{Armstrong2010ProphylaxisOC,
  title={Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.},
  author={Edward P. Armstrong},
  journal={Journal of managed care pharmacy : JMCP},
  year={2010},
  volume={16 3},
  pages={
          217-30
        }
}
BACKGROUND Vaccines have demonstrated cost-effectiveness in managed care through the prevention of disease. As new vaccines for previously untargeted conditions are developed, pharmacoeconomic modeling is becoming even more critical for the quantification of value in the health care industry. Two recently developed vaccines aimed at prevention of infection from human papillomavirus (HPV) types 16 and 18 have proven to be highly efficacious. HPV 16 and 18 are the 2 most common oncogenic strains… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 94 CITATIONS, ESTIMATED 74% COVERAGE

ESSENTIALS OF CERVICAL CANCER

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Role and uptake of human papillomavirus vaccine in adolescent health in the United States

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2011
2020

CITATION STATISTICS

  • 6 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Health and economic implications of HPV vaccination in the United States.

VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Age-based programs for vaccination against HPV.

Highlights of prescribing information. Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant] suspension for intramuscular injection

  • Merck, Co
  • Revised October
  • 2009

Long - term persistence of antiHPV - 16 and - 18 antibodies induced by vaccination with the AS 04adjuvanted cervical cancer vaccine : modeling of sustained antibody respons

  • MP David, K VanHerck, K Hardt
  • Gynecol Oncol
  • 2009